366 related articles for article (PubMed ID: 31756512)
1. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.
Musyoka KB; Kiiru JN; Aluvaala E; Omondi P; Chege WK; Judah T; Kiboi D; Nganga JK; Kimani FT
Infect Genet Evol; 2020 Mar; 78():104121. PubMed ID: 31756512
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates.
Adams T; Ennuson NAA; Quashie NB; Futagbi G; Matrevi S; Hagan OCK; Abuaku B; Koram KA; Duah NO
Parasit Vectors; 2018 Mar; 11(1):175. PubMed ID: 29530100
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
[TBL] [Abstract][Full Text] [Related]
4. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
Kavishe RA; Paulo P; Kaaya RD; Kalinga A; van Zwetselaar M; Chilongola J; Roper C; Alifrangis M
Malar J; 2014 Jul; 13():264. PubMed ID: 25007802
[TBL] [Abstract][Full Text] [Related]
7. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
[TBL] [Abstract][Full Text] [Related]
8. Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya.
Chebore W; Zhou Z; Westercamp N; Otieno K; Shi YP; Sergent SB; Rondini KA; Svigel SS; Guyah B; Udhayakumar V; Halsey ES; Samuels AM; Kariuki S
Malar J; 2020 Aug; 19(1):291. PubMed ID: 32795367
[TBL] [Abstract][Full Text] [Related]
9. Molecular surveillance of anti-malarial resistance pfcrt, pfmdr1, and pfk13 polymorphisms in African Plasmodium falciparum imported parasites to Wuhan, China.
Cheng W; Song X; Tan H; Wu K; Li J
Malar J; 2021 May; 20(1):209. PubMed ID: 33933099
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.
Ocan M; Ashaba FK; Mwesigwa S; Edgar K; Kamya MR; Nsobya SL
PLoS One; 2022; 17(5):e0268095. PubMed ID: 35511795
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.
Zhou Z; Gimnig JE; Sergent SB; Liu Y; Abong'o B; Otieno K; Chebore W; Shah MP; Williamson J; Ter Kuile FO; Hamel MJ; Kariuki S; Desai M; Samuels AM; Walker ED; Shi YP
Malar J; 2022 Sep; 21(1):265. PubMed ID: 36100912
[TBL] [Abstract][Full Text] [Related]
12. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania.
Bwire GM; Ngasala B; Mikomangwa WP; Kilonzi M; Kamuhabwa AAR
Sci Rep; 2020 Feb; 10(1):3500. PubMed ID: 32103124
[TBL] [Abstract][Full Text] [Related]
13. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
Bakari C; Mandara CI; Madebe RA; Seth MD; Ngasala B; Kamugisha E; Ahmed M; Francis F; Bushukatale S; Chiduo M; Makene T; Kabanywanyi AM; Mahende MK; Kavishe RA; Muro F; Mkude S; Mandike R; Molteni F; Chacky F; Bishanga DR; Njau RJA; Warsame M; Kabula B; Nyinondi SS; Lucchi NW; Talundzic E; Venkatesan M; Moriarty LF; Serbantez N; Kitojo C; Reaves EJ; Halsey ES; Mohamed A; Udhayakumar V; Ishengoma DS
Malar J; 2024 Mar; 23(1):71. PubMed ID: 38461239
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
[TBL] [Abstract][Full Text] [Related]
15. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Tadele G; Jawara A; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L
Malar J; 2023 Jun; 22(1):171. PubMed ID: 37270589
[TBL] [Abstract][Full Text] [Related]
16. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment.
Maniga JN; Samuel M; John O; Rael M; Muchiri JN; Bwogo P; Martin O; Sankarapandian V; Wilberforce M; Albert O; Onkoba SK; Adebayo IA; Adeyemo RO; Akinola SA
Malar J; 2023 Mar; 22(1):87. PubMed ID: 36894982
[TBL] [Abstract][Full Text] [Related]
17. Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.
He Y; Campino S; Diez Benavente E; Warhurst DC; Beshir KB; Lubis I; Gomes AR; Feng J; Jiazhi W; Sun X; Huang F; Tang LH; Sutherland CJ; Clark TG
PLoS One; 2019; 14(3):e0213686. PubMed ID: 30883571
[TBL] [Abstract][Full Text] [Related]
18. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
[TBL] [Abstract][Full Text] [Related]
19. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
